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Experimental studies
The “Experimental studies”, published either as original
papers or as brief communications, focused on four main
subjects, i. e. the mechanisms of lung injury and therapies,
the treatment of burns and trauma, multiple organ failures
and the pathophysiology and treatment of sepsis, severe
sepsis and septic shock.
Lung injury: mechanical ventilation – from mechanisms
to therapies
Aspiration of gastric contents frequently results in acute
lung injury and acute respiratory distress syndrome
(ARDS). Because the acid aspiration model of acute
lung injury has considerable clinical implications, Fraisse
et al. [1] sought to deﬁne the relationship between oxy-
genation and hemodynamic proﬁle during an acute phase
of acid aspiration in rabbits. Inhalation of human gastric
juice (1ml/kg) markedly decreased PaO2/FiO2 ratio and
increased airway plateau pressure within 1h. Lung injury
was characterized by pulmonary edema, hemorrhage,
necrosis, polymorphonuclear leukocyte inﬁltration, and
hyaline membranes, using a PaO2/FIO2 threshold value of
150.
The levels of pH, mean arterial pressure, and cardiac
output were signiﬁcantly lower after acid aspiration. How-
ever,neither left nor right ventricular dysfunctionoccurred
during the 4-h experiment, and no animal experienced
circulatory failure. This study provided Intensive Care
Medicine readers with a PaO2/FiO2 threshold. If the P/F
ratio is well above the threshold, it suggests that the lung
injury and inﬂammatory responses may be independent of
any compromised hemodynamic changes following acid
aspiration.
Several studies examined the mechanisms of
ventilator-induced lung injury in a variety of animal
models, and provided some novel insights for our read-
ers. Eyal et al. [2] tested the hypothesis that alveolar
macrophages can initiate ventilator-induced lung injury.
The investigators depleted alveolar macrophages by
intratracheal administration of liposomal clodronate 48h
prior to mechanical ventilation in rats. The animals were
then ventilated with an injurious strategy at a mean tidal
volume of 40±0.7ml/kg and zero positive end-expiratory
pressure (PEEP) for 15min. The animals were random-
ized to be sacriﬁced or to continue being ventilated for an
additional 2 h at a tidal volume less than 10 ml/kg. The
study demonstrated that oxygenation, lung compliance,
and alveolar stability were better preserved during the
initial 15-min and the subsequent 2-h ventilation in
animals with alveolar macrophages depleted. The lung
wet/dry ratio was signiﬁcantly reduced in the animals with
alveolar macrophage depletion compared to the control
groups. This study suggested that alveolar macrophages
play an important role in initiating ventilator-induced lung
injury.
Many critically ill, ventilated patients suffer from un-
explained immunosuppression that is associated with in-
creasedriskforinfections.Lachmannetal.[3]investigated
the effects of ventilatory strategies on bacterial transloca-
tion in piglets. Lung injury was induced by surfactant de-
pletion, followed by infection with intratracheal injection
of group B streptococci. The animals were then ventilated
for 5 h with either a conventionalventilatory strategy (tidal
volumeof7ml/kgandPEEP of4–5cmH2O),anopenlung
strategy(6ml/kg and14–15cmH2O), or an openlungwith
high-PEEP strategy (6ml/kg and 20–21cmH2O). The in-
vestigatorsobservedthat the open lung ventilation resulted
in signiﬁcantly less bacterial translocation than either con-
ventional or open lung with high-PEEP ventilation. This
study suggested that an optimal ventilatory strategy (i. e.,
open lung) achieved by using individually tailored settings
can be useful to minimize bacterial translocation during
mechanical ventilation.
A recent cohort study reported that non-depolarizing
neuromuscular blocking agents are used in 13% of
mechanically ventilated patients with a mean duration
of 2 days in the ICU. Testelmans et al. [4] studied the
effects of 24h infusion of rocuronium and cisatracurium
on diaphragm function in rats during mechanical venti-
lation using a tidal volume of 6 ml/kg. They observed
that the diaphragm tetanic force was decreased by 33%
in the rocuronium-treated group compared to a vehicle
control group, while the force was well preserved in the
cisatracurium-treated animals. The levels of diaphragm
muscle RING-ﬁnger protein-1 (MURF-1) mRNA and the
protease calpain were increased after rocuronium, while
unchanged in the cisatracurium-treated groups. Since
MURF-1 and calpain are molecules that may contribute to
muscle atrophy, these data suggest a role of certain non-
depolarizing neuromuscular agents in ventilator-induced
lung injury.
Endotracheal suctioning serves to clean the airway
in ventilated patients but may cause adverse effects. To
assess the effects on lung volume and compliance changes
during suctioning, Lindgren et al. [5] monitored lung
volume in four ventral-to-dorsal regions by using electric
impedance tomography and a nitrogen washout/washin
technique in surfactant-depleted, ventilated pigs. At
disconnection, before suctioning, the fractional residual
capacity (FRC) decreased by 60% of baseline. During
open suctioning, FRC decreased further to 20% of base-
line. A deterioration of regional compliance was more
pronounced in the dorsal parts of the lung. The authors
also reported that the restoration of oxygenation was
prolonged under pressure-controlled ventilation compared
to volume-controlled ventilation during the post-suction
period. It appeared that the dorsal regions of a lavaged
lung are more susceptible to disconnectionand suctioning,
resulting in marked decreases in compliance. Under231
volume-controlled ventilation, the collapsed lung and
oxygenation can be better restored from open suctioning
than under pressure-controlled ventilation.
Hemodynamic alterations during mechanical ven-
tilation may contribute to poor organ perfusion that
leads to multiple system organ dysfunction. Duperret
et al. [6] investigated the effect of gradually increased
intra-abdominal pressure on the systolic and pulse pres-
sure variations during mechanical ventilation in pigs
in the presence and absence of hypovolemia by blood
withdrawal. For a given intra-abdominal pressure, the
systolic pressure variations were greater in hypovolemic
animals than in normovolemic animals. Also, blood ﬂow
in the inferior venacava diminished as the intra-abdominal
pressure increased. This study suggested that systemic
hemodynamics can be greatly altered by intra-abdominal
pressure that leads to changes in pleural pressure, and this
effect is more pronounced during hypovolemia.
Enhanced procoagulant and depressed ﬁbrinolytic
activities may be implicated in the pathogenesis of ARDS.
Plasma protein C levels decreased in ARDS patients
compared to normal volunteers. Thrombomodulin levels
in pulmonary edema ﬂuid of ARDS patients were higher
than in normal plasma and plasma from ARDS patients.
Richard et al. [7] tested the hypothesis that if occluded
pulmonary vessels reopen with activated protein C (APC),
the ventilation-perfusion would be improved in injured
lung. Pigs were treated with intravenous infusion of
APC starting 30 min prior to oleic acid injection. The
animals were monitored for an additional 180min under
mechanical ventilation. PaO2/FIO2 was signiﬁcantly
lower in the APC-treated group before and after induction
of lung injury than in a placebo group. Lung perfusion
tended to redistribute towards dorsal regions with APC.
Total aerated lung volume was identical in the placebo
and the APC-treated animals before and after the injection
of oleic acid. The plasma concentrations of IL-6 and IL-8
were higher in the APC group 2h after oleic acid injection
than in the placebo group. In contrast to sepsis models,
pretreatment with APC resulted in worsening oxygena-
tion. The author speculated that the administration of APC
might have led to ventilation-perfusion mismatch, with
more perfusion to dependent non-aerated areas in their
model. It is noteworthy that APC exerted beneﬁcial effects
only in those critically ill patients. The present animal
model of oleic acid injection might not have reproduced
severe situations seen clinically.
The above studies addressed mechanisms and dis-
cussed several practical issues in the context of ventilator-
induced lung injury. Theoretically, lung-protective strat-
egies may be the most important primary approach to
minimize ventilator-induced lung injury. This concept is
supported by the results of the ARDSnet trial showing
a signiﬁcant reduction in the absolute mortality rate when
lower tidal volumes were used compared to higher tidal
volumes. Muellenbach et al. [8] proposed that high-
frequency oscillatory ventilation (HFOV) may be an
optimal lung-protective strategy to minimize ventilator-
induced lung injury. They investigated the effects of 24-h
mechanical ventilation by using either lung-protective
pressure-controlled ventilation (tidal volume of 6 ml/kg)
or HFOV (6Hz) in a pig model of ARDS induced by
repeated lung lavage. This study showed in a large animal
model of ARDS that the lung inﬂammation score and the
expression of IL-1β mRNA in lung tissue were signiﬁ-
cantlydecreasedin the HFOV-treatedanimals comparedto
the lung-protective pressure-controlled ventilated group.
Organ dysfunction
Acute kidney injury secondary to sepsis and septic shock
affects approximately 6% of critically ill patients. It has
been proposed that high resistance in the renal vasculature
resulted in renal hypoperfusionin a variety of animal mod-
els in which the study designs were heterogeneous. To un-
derstandthenatureofrenalbloodﬂowanditsfunctiondur-
ing recovery from experimental septic acute kidney injury,
Langenberget al. [9] recordedsystemicand renalhemody-
namics during septic acute kidney injury and subsequent
recovery in sheep. Sepsis was induced by the administra-
tion of a bolus of live Escherichia coli f o l l o w e db yac o n -
tinuous infusion for 48h. Normal saline was administered
to prevent marked hypovolemia. A bolus of gentamicin
was injected and E. coli infusion was stopped. The ani-
mals were then monitored for 48h during recovery phase
with ﬂuid administration continued. Infusion of E. coli in-
duceda hyperdynamiccirculatorystate with increasedcar-
diac output and decreased blood pressure. Acute kidney
injury was evidenced by decreased creatinine clearance.
Renal vasodilatation occurred that was accompaniedby an
increase in renal blood ﬂow. During recovery, renal blood
ﬂow returned to control levels associated with relative re-
nal vasoconstriction. Indices of tubular function decreased
during sepsis and returned to control values after 18h of
recovery.Althoughthe mechanismsresponsiblefor the de-
velopment of recovery from acute kidney injury are yet to
be elucidated, the results of this study nevertheless chal-
lenge the conventionally held paradigm of renal ischemia
as the underlyingcausefor the developmentof septicacute
kidney injury.
Ischemia and reperfusion is associated with excessive
inﬂammatory responses, and the mechanisms are very
complex. Glycogen synthase kinase-3β (GSK-3β)i s
a key regulatory enzyme in glucose metabolism that,
when activated, phosphorylates/inactivatestarget enzymes
of the insulin signaling pathway. It has been recently
reported that GSK-3β is involved in the regulation of
many cell functions, but its role in the regulation of the
inﬂammatory response remains unknown. Cuzzocrea
et al. [10] investigated the effects of TDZD-8, a potent
and selective GSK-3β inhibitor, on intestinal injury232
following ischemia/reperfusion induced by splanchnic
artery occlusion in rats. TDZD-8 was administered 5 min
prior to the 6-h reperfusion phase. The investigators
observed that the TDZD-8-treated animals had higher
blood pressure and a greater survival rate than a group
receiving vehicle control. These beneﬁcial effects were
associated with a decrease in neutrophil inﬁltration in
the reperfused intestine, attenuation of the production of
inﬂammatory cytokines and the degranulation of IκB-α,
reduction of oxidative stress, and prevention of cell apop-
tosis. This study opens a new avenue to explore the role
of GSK-3β as a therapeutic target in ischemia and reper-
fusion.
Recent ﬁndings suggest that abdominal compartment
syndrome, as reﬂected by intra-abdominal hypertension
(IAH), is associated with an increased rate of the occur-
rence of multiple organ dysfunction syndrome. Prevention
of abdominal compartment syndrome has been shown to
decrease the incidence of multiple organ dysfunction. The
inﬂammatory cytokine responses are crucial to trigger
multiple organ dysfunction in abdominal compartment
syndrome, but studies suggested that decompression
may be too late to reverse the inﬂammatory responses.
Thus early detection and prevention of abdominal com-
partment syndrome is of pivotal interest in successful
treatment. Meier et al. [11] evaluated the potential role
of microdialysis to detect intra-abdominal organ injury
during IAH by measuring energy metabolism in rats. IAH
was induced for 3h and followed by decompression and
reperfusion for another 3h. The prolonged IAH induced
persistent abdominal organ injury. Microdialysis analysis
demonstrated a signiﬁcant increase in lactate/pyruvate
and glycerol in kidney, intestine, and liver, indicating
ischemia, energy failure, and cell membrane damage. This
was accompanied by a decrease in glucose level in all
organs studied. The deterioration of energy metabolism
did not completely recover upon decompression of IAH.
This study suggested that continuous microdialysis in
the rectus abdominis muscle may provide a useful tool
for early detection of IAH-induced metabolic derange-
ments.
The loss of blood volume would be further increased
with an elevated hydrostatic capillary pressure, especially
when vascular permeability is increased. If the hypothesis
is true, this concept may lead to a potential therapeu-
tic strategy to minimize blood volume substitution in
critically ill patients by avoiding high blood pressure.
To evaluate interactions between the increased vascular
permeability and increased hydrostatic pressure on blood
volume loss, Dubniks et al. [12] induced vascular perme-
ability as a result of an anaphylactic reaction by injection
of dextran 70 in rats. Plasma volume was measured before
and after 5% albumin infusion for volume expansion.
Blood pressure was elevated by administration of nora-
drenalin or decreased by metoprolol/clonidinestarted after
the albumin infusion and continued throughout the experi-
ment. The investigators observed that the plasma volume
increased after the albumin infusion in the control group,
but to a signiﬁcantly lesser extent—by 24-fold—in the
noradrenalin-treated group in the experimental conditions
with increased vascular permeability. On the contrary, the
plasmavolumeincreasedin the noradrenalin-treatedgroup
in the normal permeability state, and this increase was
similar in extent to that seen in the metoprolol/clonidine-
treated animals under increased permeability conditions.
The study provided evidence that an increase in arterial
pressure increases the loss of plasma volume during
a state of increased permeability, perhaps due to increased
hydrostatic capillary pressure.
Head trauma and burn injury are characterized by hy-
permetabolism and hypercatabolism mediated by altered
regulatory mechanisms of hormones, imbalanced pro- and
anti-inﬂammatory cytokine production, and immune de-
pression. It has been shown that decreased production of
interleukin-2 (IL-2) and expression of the surface IL-2 re-
ceptor alpha chain (CD25) is associated with immune de-
pression in head injury. Arginine is known as a nitric oxide
donor and a precursor of polyamines for IL-2 production.
Hamani et al. [13] tested the hypothesis that standard en-
teral nutrition may not be sufﬁcient to meet speciﬁc nutri-
entdemandinheadtrauma.Theinvestigatorsexaminedthe
role of arginine in the immunomodulatory effects in a rat
model of head injury. They showed that the standard diet
supplementedwith argininereducedthymicatrophy,main-
tained thymus weight, increased the expression of CD25
and the production of IL-2, and blunted the enterobacte-
rial translocation and dissemination induced by head in-
jury. Although the beneﬁt of immune-enhancing diets in
the management of trauma injury remains controversial,
this study suggested that arginine supplement appears to
be safe, and may help modulate immune response in head
injury.
Ornithine α-ketoglutarate (OKG) has been shown to
restore glutamine pools in hypercatabolic patients and
to improve wound healing in trauma patients, but the
mechanisms remain to be elucidated. Since OKG consists
of two molecules of ornithine (Orn) and one molecule
of α-ketoglutarate (αKG), Cynober et al. [14] tested the
hypothesis that Orn and αKG interact metabolically to
produce glutamine in muscles in a rat model of 20%
surface burn injury. The animals were fed with enteral
nutrition supplemented with either OKG, Orn, or αKG.
Glycine was used as an isonitrogenous control. Higher
plasma content of glutamine and muscle contents of
glutamate and glutamine were observed in the animals
treated with the OKG-enriched diet than in those that
received diets supplemented with αKG or Orn. This study
demonstrated that OKG was more efﬁcient than Orn
or αKG alone in restoring glutamine pools in plasma
and muscle, suggesting that the metabolic interaction
between Orn and αKG is required to produce glutamine in
muscles.233
Sepsis and pneumonia models
Animalmodelsofsepsisandacutelunginjurywereusedin
several studies published in Intensive Care Medicine dur-
ing 2007. Although not perfect, these models were long
ago shown to be valuable to test pathogenic hypotheses
and potential therapies in sepsis and acute lung injury.
Left ventricular contractile dysfunction is observed in
a signiﬁcant proportion of patients with septic shock. This
sepsis-related cardiac failure is usually transitory and re-
versible. Given the high peripheral oxygen demand and
the vasodilatory shock, oxygen delivery may be insufﬁ-
cient in the early phase of septic shock in those patients.
A pharmacologic increase of cardiac output may therefore
be required in such patients. Dobutamine has been the in-
otrope of choice for several years in this condition. It is
also associated with unwanted ß-agonistic effects, which
may limit its use. Dubin et al. tested dobutamine and the
new inotrope levosimendan head-to-head in an endotox-
emic shock in sheep model [15]. Both drugs increased sys-
temic oxygen delivery by increasing cardiac output. How-
ever, only levosimendan induced an increase of intestinal
blood ﬂow and prevented the decrease in mucosal acido-
sis that was observed with dobutamine. This study, along
with others, serves as a proof-of-concept that levosimen-
dan may becomea useful drug to treat patients with septic-
associated left ventricular dysfunction. Energy utilization
by the heart is also a critical aspect of cardiac functiondur-
ing sepsis. The heart is one of the few organs using lactate
as energetic substrate. Levy and collaborators examined
whether lactate deprivation induced a cardiac and hemo-
dynamic dysfunction in a rat endotoxic shock model [16].
The combined pharmacological blockade of the ß2 recep-
tor and pyruvate dehydrogenase markedly decreased mus-
cle production of lactate, heart lactate concentration, and
tissue ATP content. This was associated with a worsen-
ing in cardiovascular performance and a poorer outcome.
These effects could be reversed by the infusion of lactate.
Thisstudyhighlightstheroleoflactateasanimportantfuel
for the heart and suggests that lactate deprivation might be
detrimental during septic shock.
Endotoxemia induces a marked increase of both pro-
inﬂammatory and anti-inﬂammatory cytokines, which are
though to be detrimental in this setting. Many efforts have
been devoted to decrease cytokine production or increase
cytokine elimination in sepsis models. It remains unclear
whether putative beneﬁcial effects of activated protein C
(aPC) are related to its anti-thrombotic and pro-ﬁbrinolytic
properties or to possible anti-inﬂammatory effects. In an
porcine model of endotoxemia, Nielsen et al. conﬁrmed
a pro-ﬁbrinolytic effect of aPC by decreasing plasma
levels of plasminogen activator inhibitor 1 [17]. However,
the effects on circulating cytokines were modest; aPC
infusion did not inﬂuence peak levels of IL-6, IL-8,
TNF-a, and IL-10, the peak occurring simply later for
the two latter. This is in accordance with the PROWESS
study, which did not show marked plasma cytokine level
differences between patients receiving aPC and controls.
Endotoxemia also induces lung inﬂammation, a phe-
nomenon largely mediated by locally produced IL-1ß. The
secretionof mature and bioactiveIL-1ß and IL-18 depends
on the activity of the enzyme caspase-1, a limiting step
in the biosynthesis of these pro-inﬂammatory cytokines.
In a series of elegant experiments, Boost and collabora-
tors showed that a caspase-1 inhibitor administered by
inhalation in endotoxemic rats decreased IL-1 and IL-18
levels in bronchoalveolar lavage ﬂuid [18]. Importantly,
downstream inﬂammatory products such as COX-2 and
nitric oxide were also decreased in animals treated with
the caspase inhibitor. In addition to the identiﬁcation
of a potential novel therapeutic target (caspase-1), this
study highlighted inhalation as a promising route for the
administration of drugs in critically ill patients.
Hemoperfusion columns are theoretically interesting
to remove noxious bacterial or host substances dur-
ing septic shock. Taniguchi et al. perfused blood from
lipopolysaccharide (LPS)-treated rats onto a cytokine
absorbent column, which resulted in a signiﬁcant reduc-
tion in plasma cytokine concentrations, and decreased
mortality, compared with controls [19]. Survival rates
were dependent on the size of the column. Oxidative
stress-induced programmed cell death has been proposed
as a mechanism participating in end-organ dysfunction
during sepsis. Ozdemir et al. showed that infant rats
injected with endotoxin had increased levels of lipid
peroxidation markers and intestinal cell apoptosis [20].
These effects were dampened by the treatment with
melatonin. This apparently harmless molecule should
be further tested for its potential role as an anti-oxidant
and for putative cytoprotective effects in the context
of sepsis. In a rat model of septic shock induced by
the staphylococcal alpha-toxin, Temmesfeld-Wollbrück
et al. showed that post-treatment with the vasoregulatory
polypeptide adrenomedullin decreased mortality [21]. The
main effect of adrenomedullin was to prevent the massive
increased vascular permeability observed in this model,
as demonstrated by a smaller diffusion of labeled albumin
in remote organs of treated animals. Mortality was also
markedly reduced in animals receiving adrenomedullin.
Staphylococcal alpha-toxin, being a pore-forming toxin,
is likely to induce signiﬁcantly more vascular damage
than other toxins such as LPS. Therefore, the effects
of adrenomedullin need to be further investigated in
endotoxemic or infectious models.
Cecal ligation and puncture (CLP) is a useful model,
mimicking peritonitis. CLP induces lethality rates de-
pending on the size of the hole(s) performed in the
cecum of mouse or rat. The advantage of this model over
endotoxemia is that live bacteria represent the infectious
challenge. Nitric oxide (NO) is produced in excess
during septic shock, due to the increased expression of
inducible NO synthase (iNOS). In a resuscitated CLP234
model, Albuszies et al. showed that glucose production
by the liver was higher in mice treated with a speciﬁc
iNOS inhibitor and in mice deﬁcient for the iNOS gene
than in littermates [22]. Increased hepatic activity of
phosphoenolpyruvate carboxykinase—a key enzyme
of gluconeogenesis—paralleled the increased glucose
production. These results suggest that iNOS-induced
excess production of NO during septic shock may down-
regulate the glucose production by the liver. High glucose
production by the liver was maintained when iNOS was
blocked or genetically absent during CLP. It has also
been suggested that NO was an important molecule
participating in the innate control of bacterial infections.
Cui et al. showed that the pharmacological inhibition and
the gene deletion of the neuronal NOS isoform increased
plasma pro-inﬂammatory cytokine concentrations and
mortality in a CLP mouse model [23]. These results
suggest that this NOS isoform is important for bacterial
clearance and cytokine production during severe bacterial
infections. In a P. aeruginosa rat model, inhaled NO
(iNO) increased pulmonary endothelial but not epithelial
permeability [24]. This effect could not be related with
modiﬁcations in levels of alveolar inﬂammation. Further
studies are needed to unravel mechanisms of iNO-induced
increase in endothelial permeability in this model. In an
original study, Tuon et al. submitted rats to CLP, followed
by ﬂuid resuscitation and antibiotic treatment [25]. They
reported that rats exhibited depressive behavior 10 days
after sepsis, as assessed by a forced swimming test.
Interestingly, these symptoms could be reversed by the
treatment with the anti-depressive drug imipramine.
Dehydroepiandrosterone (DHEA) has been shown to
improve the outcome in some models of systemic in-
ﬂammation, although the mechanisms remain unclear.
Oberbeck et al. showed that parenteral administration of
DHEA (modestly) improved survival in a CLP mouse
model. Increased heat shock protein-70 levels, decreased
splenocyte apoptosis, and TNF release observed in treated
animals may participate in the protective mechanism of
DHEA [26].
Although the nature of ﬂuid to be used for volume
resuscitation remains a question of debate, starches have
gained popularity in some European countries during the
past decade. However, both the plasma volume expansion
capacity and the secondary effects seem to be governed by
their molecular weight and degree of hydroxyethyl substi-
tution. In a pig model of hemorrhagic shock, Eisenbach
et al. demonstratedthat three different hydroxyethylstarch
solutions with molecular weightbetween 100 and 200kDa
restored macro- and microcirculation similarly [27]. Urine
production was, however, higher in a starch preparation
of lower molecular weight, whereas plasma clearance was
less in starches with a molecular weight of 200kDa. As
a note of caution, all starch solutions had signiﬁcantly
accumulated in various organs by 6h after infusion. An-
other controversy is the use of normotonic vs. hypertonic
saline solution for volume resuscitation, particularly when
effects on lung injury are measured. In a similar shock
model in pigs, Roch et al. showed that acute hemorrhage
induced a signiﬁcant lung injury assessed histologically
with increased alveolar inﬂammation and edema [28].
However, when a strict goal-directed resuscitation pro-
tocol was applied, lung injury parameters did not differ
whether animals were resuscitated with normal saline or
with small volumes of hypertonic/hyperoncoticsaline.
It has been suggested by various clinical investigators
that treatment with antibiotics before bronchoalveolar
lavage sampling will jeopardize results that can be ob-
tained with this diagnostic procedure. Brandão da Silva
et al. modeled this situation in pneumonia models in
rats [29]. Not surprisingly, it was found that pretreatment
with antibiotics markedly decreased the diagnostic yield
of BAL cultures in animals with S. pneumoniae or P.
aeruginosa pneumonia. The direct examination of BAL
smears, however, showed that a signiﬁcant proportion of
cases of pneumonia could still be diagnosed based on
the detection of bacteria inside neutrophils (intracellular
microorganisms) despite pretreatment with antibiotics.
The importance of sampling patients with suspected pneu-
monia before initiation of a novel antibiotic therapy was
highlighted in an accompanying editorial by Timsit [30].
In a well-described ovine model of lung injury (smoke
inhalation plus bacterial pneumonia), Maybauer and
collaborators reported that ceftazidime showed numerous
beneﬁcial effects besides its antibacterial properties [31].
Ceftazidime treatment was associated with hemodynamic
stabilization, better oxygenation, and less bronchial ob-
struction. Interestingly, ceftazidime blunted the increase
in 3-nitrotyrosine observed in lungs from control animals.
Clinical studies
Brain injury
Several articles dealt with treatment, pathophysiology and
prognosis of traumatic brain injury (TBI).
Following TBI, impaired autoregulation contributes to
the increasedsensitivity of the brain to secondaryischemic
insults, especially those caused by hypotension. The con-
cept of an individualized treatment is emerging, targeting
the optimal cerebral perfusion pressure (CPP) strategy on
the basis of an impaired or intact autoregulation. Chiere-
gato et al. [32] exploited an imaging technique for evaluat-
ing the relationship between CPP and cerebral blood ﬂow
(CBF). Using xenon-CT in 162 patients with severe TBI,
theyevaluatedtheassociationbetweenglobalCBFanddif-
ferent CPP, within the 50–90mmHg range. No correlation
was evident between CPP and global cerebral blood ﬂow
in this selected cohort, probably because most of the pa-
tients were studied in a normal CPP range, and pressure
autoregulation (not tested by the authors) was preserved.235
Unfortunately testing autoregulation clinically is
a complex task. Dynamic methods of measuring cerebral
autoregulation have become an accepted alternative
to static evaluation, but a reference reliable method is
not available in clinical practice. Christ et al. [33] and
co-workers tried to improve the cross-correlation method
for non-invasive, continuous monitoring of cerebral
autoregulation, in comparison to the cuff deﬂation test.
Inter-method agreement in diagnosing an intact or im-
paired cerebral autoregulation was obtained in 73.5%
of examinations. Cross-correlation analysis might serve
as a simple, non-invasive, and continuous measure of
cerebral autoregulation. Nevertheless, as suggested by the
authors, short-term autoregulation tests and monitoring
techniques based on slow spontaneous oscillations should
not be used interchangeably. Therefore the best method
for continuous assessment of autoregulation state remains
undeﬁned and requires additional investigations.
Twostudiesofaveryearlypost-TBIphaseexploredthe
possibility of non-invasivemonitoring of intracranial pres-
sure (ICP) and of CPP target treatment, before its invasive
monitoring.Geeraertsetal.[34],inordertoevaluateanon-
invasivemethod of ICP determination,assessed at ICU ad-
missiontherelationshipbetweenopticnervesheathdiameter
(ONSD) and ICP and whether greater ONSD at patient ad-
missionwasassociatedwithhigherICPintheﬁrst48hafter
TBI. A signiﬁcantrelationshipbetweenthe greatestONSD
and admission ICP was documented and it was a suitable
predictorofhighICP.Intheearlyposttraumaticperiod,ocu-
larultrasoundscansmaybeattractivefordetectinghighICP
evenifadditionaldemonstrationsarerequired.
Ract et al. [35] evaluated the usefulness of early
transcranial Doppler ultrasound (TCD) goal-directed
therapy after severe TBI, before the availability of invasive
cerebral monitoring. When admission TCD was abnormal,
attending physicians increased CPP by infusing manni-
tol and/or norepinephrine, with normalization of TCD
recordings in 9/11 patients. After invasive monitoring,
the abnormal TCD group demonstrated higher ICP. The
use of TCD at hospital admission could allow the identi-
ﬁcation of severely brain-injured patients with potential
brain hypoperfusion. In such high-risk patients, early
TCD goal-directed therapy appears attractive in restoring
normal cerebral perfusion and might potentially help in
reducing the extent of secondary brain injury.
After ICU admission, standard and advanced mon-
itoring are utilized in order to reduce the incidence of
secondary insults and to identify the heterogeneity of
this pathology. Longhi et al. [36] measured in 32 TBI
patients the brain tissue oxygen tension (PtiO2)i nt h e
hypodense area and/or near the core of the contusion and
in normal-appearing brain parenchyma on computerized
tomography. PtiO2 was lower in pericontusional tissue
than in normal-appearing tissue. In pericontusional tissue,
a progressive increase of PtiO2 from pathologic to normal
values was observed over time, suggestive of a microcir-
culatory improvement. The use of advanced monitoring
system helps the clinician to reach a better understanding
of the evolving TBI pathophysiology.
In this complex pathology, early prognosis is some-
times a difﬁcult task. Ballesteros et al. [37] investigated
whether serum drained from the jugular vein of patients
with traumatic or hemorrhagic brain injury induced
apoptosis of neuronal cells in vitro and whether the apop-
totic rate correlated with patients’ outcome at 6 months.
Regional serum drained from the jugular vein induced
higher early apoptosis than systemic serum, and only early
apoptotic rate was an independent factor associated with
mortality at 6 months. This in vitro technique, combined
with clinical and radiological measurements, might im-
provethe value of prognostic models to predict acute brain
injury patients’ outcome. Korﬁas et al. [38] examined the
relationship between serum S-100B concentrations and
injury severity, clinical course, survival, and treatment
efﬁcacy after severe TBI. Serum S-100B protein reﬂects
injury severity and improves prediction of outcome after
severe TBI. S-100B might also have a role in assessing
the efﬁcacy of treatment after severe TBI, demonstrating
a reduction after surgery.
Subarachnoid, intracerebral hemorrhage and brain death
Updated information on aneurysmal subarachnoid hem-
orrhage (SAH) patients is not widely available. Citerio
et al. [39] collected information on clinical practice and
current management strategies on 350 sequential cases in
22 Italian neurosurgical hospitals. Despite the increasing
trend towards interventional neuroradiologic means of se-
curing aneurysms, aneurysms were mainly clipped and an
endovascular approach was utilized in one third of cases,
with wide variation among centers. SAH was conﬁrmed
to be a multiorgan disease, with frequent extracranial and
intracranial complications. Nevertheless, only high ICP
and deterioration in neurological status were independent
factors related to unfavorable outcome.
Conﬁrming the multiorgan nature of this pathology,
Terao et al. [40] determined the prevalence and the
prognostic signiﬁcance of microalbuminuria in SAH. The
prevalence rates of microalbuminuria were higher in SAH
than in the control, and the highest urinary microalbu-
min/creatinine ratio and the lowest GCS score during the
ﬁrst 8 days were the signiﬁcant predictors of unfavorable
neurological outcome.
Thenumberofpatientsunderoralanticoagulant(OAC)
therapy, and consequently the number of subject with re-
latedintracerebralhemorrhagic(ICH) complications,is in-
creasing.
Appelboam et al. [41] examined current British prac-
tice regarding the emergency medical management of ICH
patients whilst receiving OAC and to compare this with
established guidelines. Prothrombin complex concentrate236
(PCC), the gold-standard therapy to normalize hemosta-
sis during OAC, remains underused. There is considerable
variation in practice amongst clinicians and, in most cases,
practice is not in keeping with guidelines.
Vigué studied whether ultra-rapid reversal of OAC
could reduce the time to biological and surgical hemosta-
sis, and might improve outcome. All patients, including
over-anticoagulated individuals, had complete reversal of
anticoagulation immediately after the bolus of PCC. No
hemorrhagic or thrombotic adverse effect was observed.
A bolus infusion of PCC completely reverses antico-
agulation within 3min. Neurosurgery can be performed
immediately in OAC-relatedintracranial hemorrhage.This
study shows that OAC-treated patients can be managed as
rapidly as non-anticoagulated patients.
Spinal cord injury after aortic surgery still represents
a matter ofconcern.Maier et al. [42]investigatedthe effect
of the PARP-1 inhibitor INO1001 on aortic occlusion-
related porcine spinal cord injury. The selective PARP-1
inhibitor INO1001 markedly reduced aortic occlusion-
induced spinal cord injury. INO1001 might improve spinal
cord recovery after thoracic aortic cross-clamping and,
after these encouraging results, further data are required.
Two papers tested two diagnostic procedures during
brain death, i. e. CT angiography (CT-a) and bispectral
index (BIS). Quesnel et al. [43] evaluated the accuracy of
cerebral CT-a for the diagnosis of brain death. In clinically
brain-dead patients, CT-a documented opaciﬁcation of
the intracerebral vessels in a signiﬁcant percentage of the
cases. Therefore CT-a cannot be recommended as a means
of brain death diagnosis.
Wennervirta et al. [44] studied the usefulness of en-
tropy and BIS in brain-dead subjects. Both entropy and
BIS showed non-zero values due to artifacts after brain
death diagnosis. BIS was more liable to artifacts than en-
tropy. Neither of these indices are diagnostic tools, and
care should be taken when interpreting EEG-derived in-
dices in the evaluation of brain death.
Sepsis-induced brain dysfunction and delirium
Sharshar et al. [45] tried to advance in our understanding
of sepsis-inducedbraindysfunctionusingin vivomagnetic
resonance imaging.
This preliminary study showed that sepsis-induced
brain lesions (such as multiple ischemic strokes, white
and gray matter lesions) can be documented by magnetic
resonance imaging. These lesions predominated in the
white matter, worsened with increasing duration of shock,
suggesting increased blood–brain barrier permeability,
and were associated with poor outcome.
ICU delirium is a common, undiagnosed and adverse
event in critically ill patients. Ouimet et al. [46] investi-
gated whether subsyndromal delirium affects outcome.
Patients with no delirium were more likely to be dis-
charged home and less likely to need convalescence or
long-term care than those with subsyndromal delirium
or clinical delirium. A graded diagnostic scale (Intensive
Care Delirium Screening Checklist) permitted detection
of subsyndromal delirium which occurs in many ICU
patients, and which is associated with adverse outcome.
Pandharipande et al. [47] identiﬁed the prevalence
of the motoric subtypes of delirium in surgical and
trauma ICU patients. Prevalence of delirium was 70%
for the entire study population. Hypoactive delirium
was signiﬁcantly more prevalent than either mixed or
hyperactive delirium. In the absence of active monitoring,
however, this subtype of delirium goes undiagnosed and
the prevalence of delirium in surgical and trauma ICU
patients remains greatly underestimated.
Acute renal failure and replacement techniques
Among the controversies in acute renal dysfunction in the
critically ill patient are the mechanisms of renal shutdown
and reversibility, the early diagnosis and staging of sever-
ity, and issues concerning renal replacement therapy.
Renal arterial resistance in septic shock and the effect
of increasing mean arterial pressure with norepinephrine
thereon was studied with the help of Doppler ultrasonog-
raphy by Deruddre et al. [48] in 11 patients with septic
shock who required ﬂuid resuscitation and norepinephrine
to maintain mean arterial pressure at or above 65mmHg.
Norepinephrine was dosed for three successive periods
of 2h to achieve a mean arterial pressure of 65, 75,
and 85mmHg, respectively. At the end of each period,
hemodynamic and renal function variables were mea-
sured, and Doppler ultrasonography was performed on
interlobar arteries to assess the renal resistive index. With
increasing mean arterial pressure, urinary output increased
from 76±64 to 93±68ml/h and the resistive index
decreased from 0.75± 0.07 to 0.71±0.06. No difference
was found between 75mmHg and 85mmHg. Doppler ul-
trasonography may thus help to determine in each patient
the optimal mean arterial pressure for renal blood ﬂow
and may be a relevant end-point for treatment of septic
shock. This study suggests that decreased renal blood
ﬂow during septic shock may be a contributing factor to
renal dysfunction, which may contrast with current animal
data that argue against hypoperfusion as a pivotal event in
acute renal failure (ARF) during endotoxemia.
Herrera-Gutiérrez et al. [49] wondered whether early
diagnosis of acute renal failure could be based on 2-h as
opposed to 24-h creatinine clearance (CrCl) in the ICU.
They studied 359 patients and compared the measures,
also with the estimated clearance from the Cockcroft–
Gault (Ck-G) equation. The mean Ck-G value was
87.4±3.0, with 2-h CrCl of 109.2± 4.5ml/min/1.73m2
and 24-h CrCl of 100.9±4.2ml/min/1.73 m2 (r2 =0. 88
for CrCl-2h and r2 = 0.84 for Ck-G). The differences from237
24-h CrCl were 21.8±3.3 for the Ck-G and 8.3±2.6 for
2-h CrCl. Patients with CrCl <100ml/min only showed
variability in hyperglycemia during the 24-h period.
Hence, 2-h CrCl is an adequate substitute for 24-h CrCl,
even in patients who are unstable or who have irregular
diuresis where a 24-h collection is unpractical. The Ck-G
equation seems less useful. These ideas can be utilized
in attempts to improve prognosis of patients by earlier
diagnosis of acute renal failure and subsequent measures
to prevent further deterioration.
Jenq et al. [50] studied whether the new RIFLE (risk,
injury, failure, loss and end stage) classiﬁcation can pre-
dict short-term prognosis in critically ill cirrhotic patients.
This study analyzed the outcomes of critically ill cirrhotic
patients and identiﬁed the association between prognosis
and the RIFLE classiﬁcation,in comparisonwith otherﬁve
scoring systems, in Taiwan. Thirty-two demographic,clin-
ical and laboratory variables were analyzed as predictors
of survival in 134 patients. Overall hospital mortality was
66%. There was a progressive increase in mortality based
on RIFLE classiﬁcation severity. Multiple logistic regres-
sion analysis indicated that RIFLE classiﬁcation and Se-
quential Organ Failure Assessment (SOFA) score on the
ﬁrst day of ICU admission were independent risk factors
for hospitalmortality.By usingtheareasunderthe receiver
operating characteristic curve (AUROC), the RIFLE cate-
gory and SOFA score both indicated good discrimination
(AUROC 0.84± 0.04 and 0.92±0.02 respectively). Cu-
mulative survival rates at 6-month follow-up differed for
non-ARF vs. R, I, and F. This study again shows the prog-
nostic value of staging ARF by the RIFLE criteria.
Maccariello et al. [51] also studied the RIFLE classiﬁ-
cation in patients with ARF in need of renal replacement
therapy. They included 214 patients, and continuous renal
replacement therapy was used in 179 (84%); patients were
classiﬁed as risk (25%), injury (27%), or failure (48%).
Overall mortality was 76% but there were no differences
according to RIFLE classiﬁcation (Risk 72%, Injury
79%, Failure 76%). Various variables were selected in
multivariate analysis, including start of renal replacement
therapy after the ﬁrst day of ICU, but the RIFLE stages did
not contribute. However, a subgroup analysis of patients
on mechanical ventilation and vasopressors found the F of
RIFLE to be associated with increased mortality. Hence,
this study does not conﬁrm the independent prognostic
signiﬁcance of the RIFLE criteria and argues in favor of
further reﬁnement.
ARF in critically ill patients still carries high mortality,
and a high proportion of these patients require renal re-
placement therapy (RRT) during their illness. To evaluate
the efﬁciency of RRT, usually urea kinetic modeling is
used, based on a sample of dialysate. The accuracy of
this estimation in critically ill patients remains, however,
questionable, since it assumes stable urea production and
constant distribution of urea, which is not the case in crit-
ically ill patients. Ionic dialysance, which is a parameter
calculated automatically from the dialysate conductivity,
has been correlated to the effective urea clearance during
hemodialysis in chronic renal failure patients. Ridel
et al. [52] evaluated this method in critically ill ARF pat-
ients, using 31 sessions of intermittent hemodialysis(IHD)
in 31 patients. Comparing the effectiveness of the RRT,
they found a strong correlation between the Kt measured
with dialysate sampling and with the ionic dialysance
method (r = 0.96, p>0.01). Despite some limitations of
their study (small delivered RRT dose, lack of measure-
ment of the removal of intermediate-molecular weight
molecules), they conclude that this methodology might be
well suited to monitor and adapt RRT in critically ill ARF
patients.
Continuous RRT (CRRT) is often the method of choice
in critically ill patients, when intermittent methods seem
not to be appropriate. CRRT, however, is not a simple sin-
gle method—it rather consists of a continuum of different
treatment modalities which can be distinguished through
a variety of factors. Uchino et al. [53] used data available
from the B.E.S.T. study to investigate several aspects of
CRRT. They included 1006 subjects treated with CRRT
for ARF. Interestingly, they reported that approximately
a third of the CRRT treatments (33.1%) were carried out
without anticoagulation. Among those who received anti-
coagulation, unfractionated heparin (UFH) was the most
common choice, followed by sodium citrate. Only 11.7%
received a treatment dose above 35ml/kg/h, the average
being 20.4ml/kg/h. Hypotension was the most frequently
recorded complication during CRRT (observed in 18.8%
ofthepatients),followedbyarrhythmias(4.3%)andbleed-
ing episodes (3.3%). With respect to outcome, approxi-
mately one third of the patients died on CRRT. Most of
the survivors recovered renal function until their discharge
from the hospital. The authors concluded that current RRT
practice does not follow established guidelines for optimal
therapy and thus might be responsible for signiﬁcant mor-
bidity.
CRRT is associated with less chronic renal failure than
intermittent hemodialysis after ARF, according to a large,
nationwideretrospectivestudyin Sweden(Bell et al. [54]).
Theobjectiveoftheauthorswas todeterminetheimpactof
type of RRT on renal recovery in patients with acute renal
failure. A total of 2,642 patients from 32 ICUs were in-
cluded. Patients with end-stage renal disease and patients
lacking a diagnosis in the inpatient register were excluded.
Thus, 2,202 patients were studied and follow-up was com-
plete. Renal recovery and mortality were studied. There
were no differences between patients on IHD and those
on CRRT techniques regardingbaseline characteristics. Of
the 1,102 patients surviving 90 days after inclusion, 86%
were treated by continuous techniques and 14% by IHD.
Seventy-eightpatients(8%) neverrecoveredrenal function
in the CRRT group. The proportion was higher among pa-
tients treated by intermittent techniques, where 26 subjects
or 16% developed need for chronic dialysis. Mortality did238
not differ. Nevertheless, these data on a large number of
patients support the use of continuous techniques.
Baldwin et al. [55] performed a randomized controlled
comparison of continuous venovenous hemoﬁltration and
extended daily dialysis with ﬁltration, with respect to
effect on small solutes and acid–base balance. Recently,
extended intermittent dialytic techniques have been pro-
posed for the treatment of acute renal failure. Sixteen
critically ill patients were subjected in a randomized con-
trolled trial to 3 days of treatment with either continuous
venous hemoﬁltration (n=8) or extended daily dialysis
with ﬁltration (n= 8). There was no difference between
the two therapies for urea or creatinine levels. One patient
in the continuous group developed hypophosphatemia
(0.54mmol/l) at 72 h. After 3 days of treatment, there was
a mild but persistent metabolic acidosis in the extended
daily dialysis with ﬁltration group. Hence, in spite of
similar control of urea, creatinine and electrolytes, aci-
dosis was better controlled by continuous venovenous
hemoﬁltration. This study adds to the ongoing debate on
the superiority of continuous over intermittent techniques.
Another controversial issue relates to the mode of
anticoagulation of the ﬁlter. Joannidis et al. [56] compared
enoxaparin with unfractionated heparin, in a random-
ized controlled crossover study. Continuous venovenous
hemoﬁltration was performed (predilution; 2500ml/h
ultraﬁltration and 180ml/min blood ﬂow rate). Heparin-
treated patients received an initial bolus of 30U/kg and
a maintenance infusion at 7 units/kg/h, dosed to achieve
an aPTT of 40–45s. Enoxaparin-treated patients received
an initial pre-ﬁlter bolus of 0.15mg/kg and a maintenance
infusion starting at 0.05mg/kg/h, adjusted to maintain
anti-Xa activity at 0.25–0.30U/ml. Each patient received
both regimens in a crossover design. Maximum treatment
duration for each set was 72h, and 37 patients completed
both study arms. Mean ﬁlter life span was 22± 17h for
heparin and 31±25h for enoxaparin. One major bleeding
episode occurred during heparin and one during enoxa-
parin treatment. Daily costs averaged e270 and e240 for
heparin and enoxaparin, respectively. Enoxaparin can thus
be safely and cost-effectively used for anticoagulation
during continuous venovenous Hemoﬁltration, resulting
in longer ﬁlter life than with unfractionated heparin.
A next step in this debate could be a comparison with
citrate-based ﬁltration.
Continuous hemoﬁltration techniques carry the dis-
advantage of losses in the ultraﬁltrate. Berg et al. [57]
evaluated glutamine kinetics during supplementation and
CRRT in 12 patients randomized to receive alanyl-l-glu-
tamine i.v. for 20h before placebo, or placebo before
glutamine, on two consecutive days. Plasma and ultraﬁl-
trate glutamine concentrations were measured, and blood
ﬂow across the leg was measured to calculate efﬂux of
glutamine. Glutamine supplementation increased plasma
concentrations. Losses into the ultraﬁltrate were similar
during treatment and control days. Net glutamine balance
across the leg was also similar on treatment and control
days. The loss of glutamine into the ultraﬁltrate suggests
an augmented need for exogenous glutamine. Although
supplementation did not decrease endogenous production,
it did not aggravate losses via the ultraﬁltrate. Hence,
in dosing of glutamine supplementation in patients on
continuousvenovenoushemoﬁltrationthese factors should
be taken into account.
Endocrinology
Current paradigms in intensive care medicine include the
idea,albeitnotbeyonddoubt,thattightglucosecontroland
selected treatment by substitution doses of hydrocortisone
for relative adrenal insufﬁciency (RAI) improve outcome.
However, the mechanisms of such beneﬁts and optimal
ways to achieve them in practice are still open to discus-
sion.
Weber-Carstens et al. [58] studied the effect of low-
dose hydrocortisone on glycemic control in septic shock
patients (n=16). At baseline, a continuous 200mg/daily
hydrocortisone infusion was replaced by a single bolus of
50mg of the drug. Blood glucose was monitored hourly,
and insulin infusion was kept constant for 6h. Thereafter,
hydrocortisone and adjustment of blood glucose were
resumed according to standard treatment. Mean blood
glucose level at baseline was 7.1 mmol/l. After bolus
injection of hydrocortisone, it increased within 6h to
peak levels of mean 8.6 mmol/l. Blood glucose returned
to baseline with restoration of continuous hydrocortisone
infusion. The data thus indicate that for glycemic control
strategies, continuous infusions of hydrocortisone seem to
be preferable to bolus injections.
Another potential confounder in glucose control is
the route and continuity of nutrition. Nguyen et al. [59]
assessed the relationship between blood glucose concen-
trations and intolerance to gastric feeding in critically ill
patients in a case–controlstudy. Two-hourly blood glucose
levels and insulin requirements over the ﬁrst 10 days after
admission were assessed in 95 consecutive feed-intolerant
(nasogastric aspirate > 250ml during feed) critically ill
patients and 50 age-matched, feed-tolerant patients who
received feeds for at least 3 days. A standard insulin
protocol was used to maintain glycemia at 5.0–7.9mmol/l.
The peak glucose levels were higher before and during
enteral feeding in feed-intolerant patients. The mean and
trough levels were, however, similar between the two
groups on admission, at 24h prior to feeding, and for the
ﬁrst 4 days of feeding. The variations over 24h before
and during enteral feeding were greater in feed-intolerant
patients. A blood glucose level greater than 10mmol/l was
more prevalent in patients with feed intolerance. The time
taken to develop feed intolerance was inversely related
to glycemia at admission. Feed intolerance in critically
ill patients is thus associated with a greater degree of239
glycemic variation and hyperglycemia. The data suggest
that more intensive insulin therapy may be required
to minimize feed intolerance. Obviously, deciding on
cause–effect relationships in this matter is hard, since
ﬂuctuation of enteral feeding and absorption could easily
affect glucose control as well.
Apart from confounding factors in glucose control,
the manner by and degree to which tight glucose control
is achieved is important. Meynaar et al. [60] evaluated
the performance of a nurse-driven computerized insulin
protocol in combination with bedside glucose measure-
ments to maintain glycemia at 4.5–7.5mmol/l, in a mixed
adult ICU (n= 182 patients). Mean glucose decreased
from 9.23mmol/l prior to the protocol to 7.68mmol/l with
the ﬁnal protocol aiming at glycemia of 4.5–7.5mmol/l.
Fifty-three percent of glucose measurements were
within the target range, one episode of hypoglycemia
(glucose≤2.2 mmol/l) occurred, representing 0.5% of pa-
tients or 0.05% of glucose measurements. The combined
strategy of successively more ambitious nurse-driven
(computerized) insulin protocols and bedside glucose
measurements resulted in acceptably low glucose levels
with very few episodes of hypoglycemia. This is a careful
study on how to achieve tighter control of glycemia with
the help of the ICU nurses and point-of-care glucose
measurements, preferably in arterial blood.
Lacherade et al. [61] studied failure to achieve
glycemic control despite intensive insulin therapy in
a medical ICU. The authors assessed the efﬁcacy of an
insulin treatment strategy in maintaining normoglycemia,
and compared ICU mortality in patients (n= 105) who
did and did not reach normoglycemia (≤7 mmol/l).
Failure to control (mean glucose> 7 mmol/l after initial
hyperglycemia correction) occurred in 32 patients and
was associated with an increase in ICU mortality (56%
vs. 23% in patients with successful control). In the
multivariate analysis, failure to control independently
predicted death in the ICU. This study emphasizes the
difﬁculty of achieving tight control in complex medical
cases but does not indicate whether failure is a marker
or a mediator of a downhill course. The accuracy of
bedside capillary blood glucose measurements in crit-
ically ill patients was the subject of study by Critchell
et al. [62]. They compared the accuracy of ﬁngerstick
with laboratory venous plasma glucose measurements
(laboratory glucose) in medical ICU patients (n=80)
and evaluated the factors involved (n= 277). Accuracy
was deﬁned as the percentage of paired values not in
accord (>0.83mmol/l difference for laboratory values
< 4.1mmol/l and > 20% difference for laboratory values
> / =4.1 mmol/l). Outliers (blood glucose difference
> 5.6mmol/l) were excluded from analyses. Mean ﬁnger-
stick glucose was 7.2 ±2.5mmol/l and mean laboratory
glucose 6.8±2.4 mmol/l. The correlation coefﬁcient was
0.91 (Clinical and Laboratory Standards Institute thresh-
old 0.9751). The mean difference (bias) between the two
methods was 0.48±1.0 mmol/l, and limits of agreement
were +2.5 mmol/l and –1.6mmol/l. Fifty-three paired
measurements (19%) in 22 patients were not in accord. In
83% of these measurements, ﬁngerstick was higher than
laboratory glucose. The ﬁndings suggest that capillary
blood glucose measured by ﬁngerstick is inaccurate in
critically ill patients, does not meet the CLSI standard and
should be used with great caution in protocols of tight
glycemic control. This type of study teaches us how to
achieve tight glucose control at the bedside.
In addition to the increasing knowledge on the im-
portance of glucose control, insight into the mechanisms,
diagnosis and therapeutic consequences of adrenocortical
dysfunction in the critically ill is expanding. The pitu-
itary–adrenal response to human corticotropin-releasing
hormone (hCRH) in critically ill, mechanically ventilated
patients (n= 37) was studied by Dimopoulou et al. [63].
A morningblood samplewas obtainedto measurebaseline
cortisol, corticotropin (ACTH) and cytokines. Patients
were then injected with 100µg hCRH, and plasma cortisol
and ACTH were measured over 2h. Baseline and peak
cortisol concentrationsfollowinghCRH were 16±5µg/dl
and 21± 5µg/dl, and median baseline and peak ACTH
levels 23pg/ml and 65pg/ml, respectively. Higher ACTH
levels and longer release of cortisol were noted in non-
survivors (n= 18) than in survivors (n=19). Furthermore,
non-survivors had higher concentrations of interleukin 8
and 6 than survivors. Hence, critically ill patients with
the highest degree of inﬂammatory proﬁle who ultimately
die particularly demonstrate altered pituitary–adrenal axis
responses to hCRH. The data in fact argue in favor of
activation of the hypothalamus–pituitary–adrenal axis as
a function of disease severity and subsequent stress but do
not indicate whether this response is sufﬁcient or not.
RAI in patients with severe acute pancreatitis was
studied by De Waele et al. [64]. This study aimed to
analyze the incidence of RAI, to identify risk factors, and
to describe how RAI affects outcome. In this prospective
study, 25 patients with severe acute pancreatitis were
subjected to a short 250µg ACTH test within 5 days after
admission. Median baseline cortisol level was 26.6µg/dl
and increased upon ACTH to 43.2µg/dl and 48.8µg/dl
after 30 and 60min, respectively. RAI (increment in
cortisol <9µg/dl) was found in 16% of all patients and in
27% of patients with organ dysfunction. Patients with RAI
were more severely ill and had higher SOFA scores. All
patients with RAI developed pancreatic necrosis, and all
of them needed surgical intervention. Twenty-eight-day
mortality was higher in patients with RAI (75% vs. 5%).
That increasingdisease severity is a risk factor for RAI has
been described before, but not the prognostic signiﬁcance
of RAI in this disease. Conversely, it is likely that RAI
was particularly a manifestation of infected pancreatic
necrosis with severe disease and dismal outcome.
The prognostic value of the adrenocortical response to
ACTH was indeed further studied by Riché et al. [65] in240
118 consecutive septic shock patients undergoing laparo-
tomy or drainage for intra-abdominal infection. Baseline
cortisol and delta cortisol to ACTH were measured during
the ﬁrst 24h following onset of shock. Baseline levels
were higher in non-survivors (39%) than in survivors,
but the response to ACTH did not differ between out-
come groups. Receiver operating characteristic curves
showed threshold values for baseline of 32µg/dl and
a delta of 8 µg/dl that best discriminated survivors from
non-survivors. There was no predictive value for hospital
survival, however. Adrenal function tests and survival
did not differ between patients who received etomidate
anesthesia (n=69) and those who did not. This study thus
sheds doubts on the prognostic signiﬁcance of ACTH test
results in abdominal sepsis.
Dimopoulou et al. [66] report on a prospective study
on adrenocortical responses and outcome prediction in
203 mixed ICU patients. Within 24h of admission to the
ICU a morning blood sample was obtained to measure
baseline cortisol, ACTH, and dehydroepiandrosterone
sulfate (DHEAS). Subsequently a low-dose (1 µg) ACTH
test was performed. Overall, 149 patients survived and
54 died. Non-survivors were older and had higher SOFA
and APACHE II scores. Non-survivors had a lesser rise in
cortisol (5.0 vs. 8.3µg/dl) and lower DHEAS (1065 vs.
1642ng/ml) than survivors. The two groups had similar
baseline and stimulated cortisol values. Multivariate logis-
tic regression analysis revealed that the incremental rise in
cortisol was an independent predictor for poor outcome.
In contrast, baseline cortisol or adrenal androgens did not
afford prognostic signiﬁcance. This study underscores
the prognostic signiﬁcance of ACTH-stimulated cortisol
but does not reveal whether the type of patient is of
importance (sepsis vs. non-sepsis).
Finally, Venkatesh et al. [67] found evidence for al-
tered cortisol metabolism in critically ill patients. Changes
in cortisol metabolism may be due to altered activity
of the enzyme 11beta-hydroxysteroid dehydrogenase
(11beta-HSD). Patients with sepsis (n= 13), multiple
trauma (n=20), and burns (n=19) were studied con-
cerning serial plasma cortisol:cortisone ratios. Compared
with controls, the plasma cortisol:cortisone ratio was
elevated in sepsis and trauma on day 1 (22±9, p= 0.01,
and 23± 19, p=0.0003, respectively) and remained
elevated over the study period. Such a relationship was not
demonstrable in burns. The ratio correlated to APACHE
II (r = 0.77, p=0.0008) and SAPS (r =0. 7, p= 0.003)
only on day 7 and only in the burns cohort. Hence, there
is evidence of altered cortisol metabolism in critical
illness due to an increase in 11beta-HSD activity, but
the precise relation with ACTH test results and clinical
features of RAI remains unclear. Taken together, the
optimal deﬁnition, clinical signiﬁcance, risk factors, and
mechanisms of adrenocortical suppression in critical
illness are still a matter of debate and subject to further
study.
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